Copellor 80mg Injection

Copellor 80mg Injection is used to treat moderate to severe plaque psoriasis and psoriatic arthritis in adults. Known internationally as Taltz, it contains ixekizumab, a monoclonal antibody that targets interleukin-17A, a protein involved in inflammatory responses. This injection is designed to reduce symptoms like inflammation, skin lesions, and joint pain, improving the quality of life for patients managing these chronic conditions.

Uses:

• Effective in managing plaque psoriasis by reducing skin scaling, inflammation, and lesions
• Treats psoriatic arthritis, alleviating symptoms such as joint pain and swelling

Side Effects:

• Common side effects include injection site reactions, upper respiratory infections, and headache.
• Rare but serious side effects may include severe allergic reactions or increased risk of infection. Seek medical guidance if these occur.

Key Features:

• Contains ixekizumab for targeted psoriasis and psoriatic arthritis treatment
• Reduces inflammation and improves skin condition
• Injectable formulation for direct effect

References:

• Eli Lilly and Company, Electronic Medicines Compendium (EMC), [Revised on 25 May 2023], [Accessed on 17th June 2023], Link
• Eli Lilly and Company, US Food and Drug Administration, [Revised on March 2021], [Accessed on 17th June 2023], Link